Parasitology Research

, Volume 81, Issue 2, pp 132–136 | Cite as

Use of enzyme-linked immunosorbent assay and enzyme-linked immunoelectrotransfer blot for the diagnosis and monitoring of neurocysticercosis

  • C. Simac
  • P. Michel
  • A. Andriantsimahavandy
  • P. Esterre
  • A. Michault
Original Paper


A total of 70 proven cases of neurocysticercosis from la Réunion (Indian Ocean) were studied with enzyme-linked immunoassay (ELISA) and immunoelectrotransfer blot (EITB) to detect specific antibodies in serum and cerebrospinal fluid (CSF). Absorbance levels of antibody to crudeTaenia solium cyst extract as an antigen were compared with EITB banding-pattern and computed tomography-scan results. The EITB analysis of sera and CSF from patients with active neurocysticercosis, confirmed with characteristic brain-scan imaging and highest ELISA absorbance, regularly revealed two bands with molecular weights of 13 and 14 kDa, respectively. These low-molecular-weight fractions are potential markers of active cerebral cysticercosis, a result obtained in the simple epidemiological situation of La Réunion (Indian Ocean). A parallel study is underway in Madagascar, where cross-reactivities with other parasitic diseases, includingSchistosoma infections, may interfere.


Indian Ocean Cerebrospinal Fluid Immunosorbent Assay Specific Antibody Parallel Study 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alarcon F, Escalante L, Duenas G, Montalvo M, Roman M (1989) Neurocysticercosis. Short course of treatment with albendazole. Arch Neurol 46:1231–1236Google Scholar
  2. Bouillant-Linet E (1986) La cysticercose à l'Ile de La Réunion. Tomodensitométrie cérébrale: diagnostic positif et surveillance sous traitement. Thesis, Faculty of Medicine, University of ParisGoogle Scholar
  3. Correa D, Sandoval MA, harrison LJS, Parkhouse RME, Plancarte A, Meza-Lucas A, Flisser A, Flisser A (1989) Human neurocysticercosis: comparison of enzyme immunoassay capture techniques based on monoclonal and polyclonal antibodies for the detection of parasite products in cerebrospinal fluid. Trans R soc Trop Med Hyg 83:814–816Google Scholar
  4. Diaz JF, Verastegui M, Gilman RH, Tsang VCW, Pilcher JB, Gallo C, Garcia HH, Torres P, Montenegro T, Miranda F, the Cysticercosis Working Group in Peru (1992) Immunodiagnosis of human cysticercosis: a field comparison of antibody-enzymelinked immunosorbent assay (ELISA) and enzyme-linked immunoelectrotransfer blot assay (EITB) in Peru. Am J Trop Med Hyg 46:610–615Google Scholar
  5. Escobedo F, Penagos P, Rodriguez J, Sotelo J (1987) Albendazole therapy for neurocysticercosis. Arch Intern Med 147:738–741Google Scholar
  6. Estanol B, Juarez H, Trigoyen MC, Gonzalez-Barranco D, Corona T (1989) Humoral immune response in patients with cerebral parenchymal cysticercosis treated with praziquantel. J Neurol Neurosurg Psychiatry 52:254–257Google Scholar
  7. Estrada JJ, Kuhn RE (1985) Immunochemical detection of antigens of larvalTaenia solium and anti-larval antibodies in cerebrospinal fluid of patients with neurocysticercosis. J Neurol Sci 71:39–48Google Scholar
  8. Flisser A, Gonzalez D, Shkurovich M, Madrazo I, Correa D, Rodriguez-Carbajal J, Cohen S, Rodriguez-Rosal E, Collado M, Fernandez B, Fermandez F, De Aluja AS (1990) Praziquantel treatment of porcine brain and muscleTaenia solium cysticercosis. Radiological, physiological and histopathological studies. Parasitol Res 76:263–269Google Scholar
  9. Garcia HH, Martinez M, Gilman R, Herrera G, Tsang VCW, Pilcher JB, Diaz F, Verastegui M, Gallo C, Porras M, Alvarado M, Naranjo J, Miranda E, the Cysticercosis Working Group in Peru (1991) Diagnostic of cysticercosis in endemic regions. Lancet 338:549–551Google Scholar
  10. Gottstein B, Tsang VCW, Schantz PM (1986) Demonstration of species-specific and cross-reactive components ofTaenia solium metacestode antigens. Am J Trop Med Hyg 35:308–313Google Scholar
  11. Gottstein B, Zini D, Schantz PM (1987) Species-specific immunodiagnosis ofTaenia solium cysticercosis by ELISA and immunoblotting. Trop Med Parasitol 38:299–303Google Scholar
  12. Helbig M, Forsch P, Kern P, Frosch M (1993) Serological differentiation between cystic and alveolar echinococcosis by use of recombinant larval antigens. J Clin Microb 31:3211–3215Google Scholar
  13. Michault A, Coubes P, Laporte JP, Bouillant-Linet E, Leroy D (1986) Diagnostic de la cysticercose encéphalique à l'île de La Réunion par méthode immunoenzymatique. Path Biol (Paris) 36:266–270Google Scholar
  14. Michault A, Leroy D, Coubes P, Laporte JP, Bertil G, Mignard C (1989) Diagnostic immunologique dans le liquide céphalorachidien et le sérum de la cysticercose encéphalique évolutive. Path Biol (Paris) 37:249–253Google Scholar
  15. Michault A, Riviere B, Fressy P, Laporte JP, Bertil G, Mignard C (1990a) Apport de l'EITB au diagnostic de la neurocysticercose humaine. Path Biol (Paris) 38:119–125Google Scholar
  16. Michault A, Duval G, Bertil G, Folio G (1990b) Etude séroépidémiologique de la cysticercose à lîle de La Réunion. Bull Soc Pathol Exot 83:82–92Google Scholar
  17. Michel P, Callies P, Raharison H, Guyon P, Holvoet L, Genin C (1993) Epidemiologie de la cysticercose à Madagascar. Bull Soc Pathol Exot 86:62–67Google Scholar
  18. Miller B, Stugaitis SM, Toutelotte WW (1985) Intra-blood brain barrier IgG synthesis in cerebral cysticercosis. Arch Neurol 42:782–784Google Scholar
  19. Pammenter MD, Epstein SR, Rees RT (1992) Cross-reactions in the immunodiagnosis of schistosomiasis and cysticercosis by a cerebrospinal fluid enzyme-linked immunosorbent assay. Trans R Soc Trop Med Hyg 86:51–52Google Scholar
  20. Ramos-Kuri M, Montoya RM, Padilla A, Govezensky T, Diaz ML, Sciutto E, Sotelo J, Larralde C (1992) Immunodiagnosis of neurocysticercosis. Disappointing performance of serology (ELISA) in an unbiased sample of neurological patients. Arch Neurol 49:633–636Google Scholar
  21. Sotelo J, Del Brutto OH, Penagos P, Escobedo F, Torres B, Rodriguez-Carbajal J, Rubio-Donnadieu F (1990) Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. J Neurol 237:69–72Google Scholar
  22. Suss RA, Maranilla KR, Thompson J (1986) MR imaging of intracranial neurocysticercosis: comparison with CT and anatomopathological features. Am J Neuroradiol 7:235–248Google Scholar
  23. Tsang VCW, Brand JA, Boyer AE (1989) An enzyme-linked electrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 159:50–59Google Scholar
  24. Vasconcelos D, Cruz-Segura H, Mateos-Gomez H, Alanis GZ (1987) Selective indications for the use of praziquantel in the treatment of brain cysticercosis. J Neurol Neurosurg Psychiatry 50:386–388Google Scholar
  25. Wilson M, Bryan RT, Fried JA, Ware DA, Schantz PM, Pilcher JB, Tsang VCW (1991) Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis 164:1007–1009Google Scholar
  26. Zini D, Farell VJR, Wadee AA (1990) The relationship of antibody levels to the clinical spectrum of human neurocysticercosis. J Neurol Neurosurg Phsychiatry 53:656–661Google Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • C. Simac
    • 1
  • P. Michel
    • 1
  • A. Andriantsimahavandy
    • 2
  • P. Esterre
    • 2
  • A. Michault
    • 1
  1. 1.Department of ParasitologyRegional Hospital of Saint-PierreLa Réunion
  2. 2.Parasitology UnitInstitut Pasteur de MadagascarAntananarivoMadagascar

Personalised recommendations